Objective: Temporal lobe epilepsy (TLE) is one of the most common types of epilepsy syndromes in the world. Depression is an important comorbidity of epilepsy, which has been reported in patients with TLE and in different experimental models of epilepsy. However, there is no established consensus on which brain regions are associated with the manifestation of depression in epilepsy. Here, we investigated the alterations in cerebral glucose metabolism and the metabolic network in the pilocarpine-induced rat model of epilepsy and correlated it with depressive behavior during the chronic phase of epilepsy. Methods: Fluorodeoxyglucose ( 18 F-FDG) was used to investigate the cerebral metabolism, and a cross-correlation matrix was used to examine the metabolic network in chronically epileptic rats using micro-positron emission tomography (microPET) imaging. An experimental model of epilepsy was induced by pilocarpine injection (320 mg/kg, ip). Forced swim test (FST), sucrose preference test (SPT), and eatingrelated depression test (ERDT) were used to evaluate depression-like behavior. Results: Our results show an association between epilepsy and depression comorbidity based on changes in both cerebral glucose metabolism and the functional metabolic network. In addition, we have identified a significant correlation between brain glucose hypometabolism and depressive-like behavior in chronically epileptic rats. Furthermore, we found that the epileptic depressed group presents a hypersynchronous brain metabolic network in relation to the epileptic nondepressed group. Significance: This study revealed relevant alterations in glucose metabolism and the metabolic network among the brain regions of interest for both epilepsy and depression pathologies. Thus it seems that depression in epileptic animals is associated with a more diffuse hypometabolism and altered metabolic network architecture and plays an important role in chronic epilepsy.
| INTRODUCTION
Temporal lobe epilepsy (TLE) is one of the most common types of epilepsy syndromes in the world. 1 Patients with TLE show psychiatric features including memory and cognitive impairments, as well as depressive and mood dysfunctions. 2 Studies have elucidated a strong relation between epilepsy and depression. 3 However, there is no established consensus about which brain regions are specifically related to the development of depression in epilepsy. Dysfunctions in the temporal lobe and frontal lobe structures are frequently found in TLE, which has been related to depression. Furthermore, depression-like behavior has been reported in experimental models of epilepsy. 4, 5 Cerebral glucose metabolism, analyzed with fluorodeoxyglucose ( 18 F-FDG) positron emission tomography (PET), is widely used as a static measure; however, 18 F-FDG can be also used to study metabolic networks because of the possibility of coupling between the brain activity and glucose metabolism. 6 Studies have demonstrated network abnormalities in epilepsy. 6, 7 The establishment and validation of animal models of depression comorbidity in epilepsy are fundamental for understanding the mechanisms of this condition. The use of radiopharmaceuticals in epilepsy offers an opportunity to investigate an ontological relationship between the limbic hypometabolism observed in epilepsy and the effects of seizures and its pathophysiological basis. 8 18 F-FDG has been used widely to investigate the cerebral metabolism in patients with TLE and recently in small animals using microPET imaging. These methodologies are analogous to those available clinically, thereby facilitating the translation of the methods and results obtained in the experimental context. In the present study, we investigated brain glucose metabolism and the metabolic network in chronically epileptic rats and correlated with depressive comorbidity using microPET as a noninvasive imaging tool. Furthermore, different behavior tests were performed to confirm the depression-like behavior in this animal model of epilepsy.
| METHODS

| Animals and epilepsy model
Fifty male Wistar rats (CrlCembe:WI) at 40-45 days of age were used for the control and epilepsy groups. This study was performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by the Animal Care and Use Committee of Pontifical Catholic University of Rio Grande do Sul (PUCRS) (#7293).
Thirty-seven rats received pilocarpine (320 mg/kg, Sigma-Aldrich, St. Louis, MO, USA) intraperitoneally (ip), as described previously in reports of our studies. [9] [10] [11] First, rats were pretreated with methylscopolamine (1 mg/kg ip; Sigma-Aldrich). After 90 minutes of status epilepticus (SE) initiation, the animals received diazepam (10 mg/kg, ip) to interrupt the behavioral manifestations. The Racine scale was used to classify the epileptic behavior. 12 Only animals that showed grade 5 seizures were included in the study. Fifteen days after SE induction, the surviving animals were video-monitored 12 h/d (6-h light cycle and 6-h dark cycle) until the last scan day (46 days post-SE) for the observation of spontaneous recurrent seizures (SRS) and analyzed by 2 trained observers. Only grade 5 seizures were counted. 9 Six rats did not exhibit SRS and were excluded from the study. Pilocarpine-injected rats were divided into 2 groups: Pilocarpine Depressed (Pilo Depressed) group and Pilocarpine Nondepressed (Pilo Nondepressed) group. For the composition of the first group we considered those animals that presented depressive-like behavior in at least 2 behavior tests. Control animals received intraperitoneal saline injection instead of pilocarpine. The experiments are illustrated in Figure 1 .
|
F-FDG microPET scan
For the cerebral metabolism studies, a TriumphmicroPET (LabPET-4, TriFoil Imaging, Northridge, CA, USA) was used at the Preclinical Research Center of the Brain Institute. On each scan day, the animals were anesthetized individually using a mixture of isoflurane and oxygen (3%-4% induction and 2%-3% maintenance), and 1 mCi of 18 F-FDG was administered through the tail vein. The animals were returned to the cage for a 40-minute period of conscious tracer uptake and were placed on a heat plate to maintain the body temperature at approximately 36°C. After the uptake period, the rats were placed in a supine position on the heated bed of the equipment with the field of view centered on the animal's head. The static acquisition was performed under inhalational anesthesia for 10 minutes. The animals were scanned on 23, 29, 36, and 46 days post-SE.
| Image reconstruction and brain connectivity network construction
After the acquisitions, the data were reconstructed using a 3-dimensional maximum likelihood expectation maximization (3D-MLEM) algorithm with 20 iterations and without attenuation and scatter corrections. Each reconstructed brain image was spatially normalized using an 18 F-FDG brain image template through PMOD 3.5 software and the Fusion toolbox (PMOD Technologies, Zurich, Switzerland). A magnetic resonance imaging (MRI) rat brain voxel of interest (VOI) template was used to overlay the normalized, previously co-rotated images to the microPET imaging database, and 29 VOIs were used. Glucose uptake in all brain regions was normalized by the pons and expressed as relative standardized uptake value (SUVr). 13 In addition, the voxel-based analysis was performed using the statistical parametric mapping (SPM 12) software (Wellcome Trust Center for Neuroimaging) using the SAMIT and WFU toolboxes. The images were smoothed with an isotropic Gaussian kernel of 1.2 mm. Only regions with more than 400 voxels were reported as significant. 14 Regional SUVr values were used for metabolic network analyses. Symmetric matrices were constructed by crosscorrelation coefficient analyses using VOIs associated with epilepsy and depression (left and right hemispheres, 20 9 20 matrices). Resulting uncorrected matrices were corrected for multiple comparisons with false discovery rate (FDR) (P < .05). Network analysis was conducted using Matlab. 15 
| Forced swim test (FST)
The forced swim test, described by Porsolt and colleagues 16 is used to measure depressive behavior in animals. In this study, we used the protocol described previously. 17 
| Sucrose preference test (SPT)
To analyze anhedonia, the sucrose preference test was used. 17 On the first day, the animals were trained to adapt to sucrose solution for 24 hours. Animals were housed in individual cages with free access to 2 identical bottles, each containing 100 mL of 1% sucrose and food provided ad libitum. On the second day, the animals had free access to 2 bottles, one containing 100 mL of 1% sucrose and the other containing 100 mL of water and food provided ad libitum. On the third day, the animals were deprived of water and food for 22 hours. On the last day, the animals had free access to 2 bottles, one containing 100 mL of 1% sucrose and the other containing 100 mL of water. After 2 hours of testing, water and sucrose consumption were measured.
| Eating-related depression test (ERDT)
This test examines the levels of depression and motivation to eat after food deprivation. 17 In this test, all food was removed from the animal cages for 24 hours. After, a few food pellets were placed on a piece of filter paper positioned at one of the 4 corners of the home cage, and each animal was placed in a corner opposite to the food, free to explore for 5 minutes. To exclude odor-related issues, the food pellets were changed for each rat. The latency of the first bite was measured. were performed using PrismGraph 6.0 software (GraphPad Software, San Diego, CA, USA). Data were expressed as mean AE SEM, and a significance level of P < .05 was considered statistically significant for all variables.
3 | RESULTS
| Brain glucose metabolism at 23 days post-SE
Epileptic depressed animals showed cerebral 18 F-FDG whole-brain hypometabolism in comparison to control animals ( Figure 2A ,B, P < .001). In addition, regional hypometabolism was identified in the left hippocampus, both sides of the amygdala, cingulate cortex, entorhinal cortex, insular cortex, medial prefrontal cortex, orbitofrontal cortex, ventral tegmental area (VTA), thalamus, and right cerebellum. When compared to nondepressed animals, epileptic depressed rats showed cerebral 18 F-FDG hypometabolism on both sides of the thalamus. The Pilo Nondepressed group presented hypometabolism in comparison to the control group in the left hippocampus, cingulate cortex and insular cortex, both sides of the amygdala, entorhinal cortex, and orbitofrontal cortex. Data on other brain regions, as well as mean AE SEM and P-values are described in Figure S1 and Table S1 .
| Brain glucose metabolism at 29 days post-SE
In this period, we verified cerebral 18 F-FDG hypometabolism in the Pilo Depressed group in relation to the Control group in the whole brain ( Figure 2A ,B, P < .001). In addition, regional hypometabolism was detected on both sides of the hippocampus, amygdala, cingulate cortex, entorhinal cortex, insular cortex, medial prefrontal cortex, VTA, thalamus, cerebellum, and orbitofrontal cortex.
Rats in the Pilo Depressed group were hypometabolic compared to Pilo Nondepressed group in both sides of thalamus and left cerebellum.
The Pilo Nondepressed group showed decreased glucose metabolism in comparison to the Control group in the whole brain ( Figure 2A ,B, P < .001), both sides of the hippocampus, amygdala, cingulate cortex, entorhinal cortex, insular cortex, medial prefrontal cortex, VTA, thalamus, and orbitofrontal cortex. In addition, hypometabolism was detected in the right cerebellum. Other brain regions, mean AE SEM, and P-values are described in Figure S1 and Table S2 .
| Brain glucose metabolism at 36 days post-SE
The epileptic depressed animals showed cerebral 18 F-FDG hypometabolism in comparison to Control animals in the whole brain ( Figure 2A ,B, P < .001). In addition, regional hypometabolism was identified on both sides of the hippocampus, amygdala, cingulate cortex, entorhinal cortex, insular cortex, medial prefrontal cortex, VTA, thalamus, cerebellum, and orbitofrontal cortex. The Pilo Depressed group presented decreased brain glucose metabolism in relation to the Pilo Nondepressed group in the whole brain ( Figure 2A ,B, P < .05). Furthermore, regional hypometabolism was found on both sides of the thalamus and left cerebellum, as well as other regions (Table S3) .
The epileptic nondepressed animals demonstrated brain glucose hypometabolism when compared to control animals in the whole brain ( Figure 2A ,B, P < .01). In addition, regional hypometabolism was showed on both sides of the hippocampus, amygdala, cingulate cortex, entorhinal cortex, insular cortex, medial prefrontal cortex, VTA, thalamus, and orbitofrontal cortex.
Other brain regions, mean AE SEM, and P-values are described in Figure S1 and Table S3 .
| Brain glucose metabolism at 46 days post-SE
At 46 days post-SE, epileptic depressed animals presented whole brain hypometabolism when compared to control animals ( Figure 2A ,B, P < .001).
18 F-FDG hypometabolism was also seen in both sides of the hippocampus, amygdala, cingulate cortex, entorhinal cortex, insular cortex, medial prefrontal cortex, and thalamus, and the right VTA and left orbitofrontal cortex. Pilo Depressed animals showed hypometabolism in comparison to Pilo Nondepressed animals in the whole brain ( Figure 2A ,B, P < .05), as well as other regions (Table S4) .
Epileptic nondepressed animals compared to control animals showed a lower cerebral glucose metabolism in the whole brain (Figure 2A ,B, P < .001), both sides of the hippocampus, amygdala, cingulate cortex, entorhinal cortex, insular cortex, medial prefrontal cortex, thalamus, and orbitofrontal cortex, and also in both right VTA and cerebellum.
Other brain regions, mean AE SEM, and P-values are described in Figure S1 and Table S4. 3.5 | Temporal analysis of brain 18 
F-FDG metabolism in experimental groups in post-SE periods
The results of the temporal analysis of 18 F-FDG metabolism showed an increase in glucose uptake in the Control group in the whole brain ( Figure 2B ; 23 vs 29 days, P < .05). The temporal analysis was also observed for several brain structures when individually analyzed ( Figure S1 ). The mean AE SEM and P-values of each brain region are described in Table S5 . Conversely, in the Pilo Depressed group, there was a visible decrease in the whole brain glucose metabolism ( Figure 2B ; 23 vs 29 days, P < .05), and in different time points in the individually analyzed brain areas ( Figure S1 ). The mean AE SEM and P-values of each brain region are described in Table S6 .
The Pilo Nondepressed group did not show brain glucose metabolism alteration during temporal analysis in the , and 46 days post-SE. On day 23, the Pilo Depressed group showed hypometabolism in relation to the Control group (***P < .001) On day 29, the Pilo Depressed and Pilo Nondepressed groups showed hypometabolism in relation to the Control group (***P < .001; § § §P < .001, respectively). On day 36, the Pilo Depressed and Pilo Nondepressed groups showed hypometabolism in relation to the Control group (***P < .001; § §P < .01, respectively), and the Pilo Depressed group showed a significant reduction in glucose metabolism compared to the Pilo Nondepressed group (#P < .05). On day 46, animals in the Pilo Depressed and Pilo Nondepressed groups showed hypometabolism in relation to control animals (***P < .001; § § §P < .01, respectively), and compared to the Pilo Nondepressed group, the Pilo Depressed group showed a significant reduction in glucose metabolism (#P < .05). In the temporal analysis, within the same group, glucose metabolism in the Control group is significantly elevated between 23 and 29 days (+P < .05). The Pilo Depressed group shows a decrease in metabolism between the evaluated periods, being significant between 23 and 29 days (+P < .05). Data are expressed as the mean AE SD. GEE test with repeated measures and Pvalues were corrected with False Discovery Rate (FDR), n = 13 Control group; n = 11 Pilo Depressed group; n = 9 Pilo Nondepressed group. SUVr, relative standardized uptake value; SE, status epilepticus; GEE, generalized estimation equation; SD, standard deviation; Figure S1 ). The mean AE SEM and P-values of each brain region are described in Table S7. 3.6 | Analysis of brain glucose metabolism using statistical parametric mapping (SPM)
Using SPM, we observed several hypometabolic regions 46 days after SE when the Pilo Depressed group was compared to the Control group ( Figure S2) . Nevertheless, we found no difference when the Pilo Nondepressed group was compared to Control group or Pilo Depressed group. The number of voxels and mean AE SD of T values are described in Table S8 .
| Changes in metabolic network at 46 days post-SE
We analyzed the metabolic network at 46 days post-SE to capture potential network remodeling in chronically epileptic animals. We first defined the control group metabolic network ( Figure 3A,D) . Of interest, epileptic depressed animals showed metabolic hypersynchronicity (higher number of significant connections, Figure 3B ,E). By contrast, compared to the epileptic depressed group, epileptic nondepressed rats presented substantially reduced significant connections in the metabolic network. Nevertheless, both epileptic groups presented some similar abnormal significant connections, which seem related only to epileptic features, but not to depressive-like behavior. However, if compared to the control group, the epileptic nondepressed metabolic network presents increased synchronicity (Figure 3C,F) . Our results suggest a remodeling in the brain metabolic architecture in the chronically epileptic rats presenting depressive-like comorbidities.
| Correlation between brain 18
F-FDG metabolism and seizure frequency during chronic epilepsy
All epileptic animals were video-monitored throughout the imaging studies to quantify SRS. Animals in the Pilo Nondepressed group had an average of 53 seizures in the evaluated period (53.78 AE 1.87, mean AE standard deviation [SD]). Epileptic depressed animals presented about 58 seizures during the same period (58.27 AE 2.29, mean AE SD) ( Figure 4A ). The animals showed no difference in the seizure frequency over the analyzed time points during the chronic period of epilepsy (data not shown), and we found no correlation between seizure frequency and cerebral glucose metabolism in the whole brain at 46 days post-SE between both Pilo Depressed and Pilo Nondepressed groups ( Figure 4B ).
| Depressive-like behavior in epileptic animals during SPT, FST, and ERDT
In the SPT, rats in the Control group and Pilo Nondepressed group showed a preference for drinking sucrose solution over water (P < .001; P < .01, respectively, Figure 5A,C) . Conversely, epileptic depressed animals consumed water and sucrose solution in similar proportions, showing no preference for sucrose ( Figure 5B ). When the 3 groups were compared, epileptic depressed animals consumed less sucrose than the Control and Pilo Nondepressed group (P < .001; P < .01, respectively; Figure 5D ). Regarding total volume consumption, we did not identify differences between groups (data not shown).
In the FST, during the first 5 minutes of the test, epileptic depressed rats spent more time immobile compared to control and epileptic nondepressed rats (P < .05; P < .01, respectively, Figure 5E ). In the last 5 minutes of the test, a similar result was observed when the Pilo Depressed group was compared to Control and Pilo Nondepressed groups (P < .05, Figure 5F ). Thus, the analysis of the total 10 minutes showed that the Pilo Depressed group demonstrated a longer time immobile in water compared to the Control and Pilo Nondepressed group (P < .01, Figure 5G) .
In the ERDT, rats in the Pilo Depressed group took longer time to eat than rats in the Control group and Pilo Nondepressed group (P < .01, Figure 5H ).
| Correlation between brain 18 F-FDG metabolism and depressive behavior during chronic epilepsy (46 days post-SE)
We observed a correlation between cerebral glucose metabolism and depressive-like behavior in the whole brain (Figure 6 ) and in different brain regions associated with epilepsy and depression in the epileptic rats (Table S9 ). We observed positive correlation when 18 F-FDG metabolism was compared to sucrose consumption in SPT in the whole brain (r = .3867; P = .0262; Figure 6A ), entorhinal cortex (r = .4676; P = .0061), insular cortex (r = .4416; P = .0101), medial prefrontal cortex (r = .3559 P = .0421), and hippocampus (r = .3965; P = .0224). When we compared cerebral glucose metabolism and time spent in immobility during FST, we found no correlation in the whole brain (r = À.2470; P = .1658; Figure 6B ); however, we found significant negative correlation in the amygdala (r = À.3504; P = .0456), cingulate cortex (r = À.4734; P = .0054), and hippocampus (r = À.3741; P = .0320). In addition, when we compared cerebral glucose metabolism and latency for the first bite in ERDT, we did not identify a correlation in the whole brain (r = .1156; P = .5218; Figure 6C) . However, there was a weak negative correlation in the entorhinal cortex (r = À.3734; P = .0323). All regions are described in Figure S3A -C, and the correlations of the other brain regions analyzed are reported in Table S9 . 
| DISCUSSION
In the present study, we demonstrated that a group of chronically epileptic rats also showed depression-like behavior. Furthermore, epileptic depressed and epileptic nondepressed animals showed lower brain 18 F-FDG metabolism when compared to control animals in the whole brain and in several brain regions. In addition, Pilo Depressed rats presented a more widespread hypersynchronous metabolic network, with aberrant connections in brain regions related to the pathophysiology of both epilepsy and depression. In addition, we found a correlation between the severity of cerebral glucose hypometabolism and depression-like behavior in chronically epileptic rats. Our results showed a lower 18 F-FDG metabolism in the brain of chronically epileptic animals, at different time points in several regions, such as the hippocampus, amygdala, cingulate cortex, insular cortex, orbitofrontal cortex, medial prefrontal cortex, thalamus, and VTA. These regions are related to the pathophysiology of both epilepsy and depression, and they have fundamental importance in cognitive and depression-like behavior. 6, 13, 18 Fitzgerald and colleagues reported that the dorsal cingulate cortex, medial and dorsolateral prefrontal cortex, insular cortex, and superior temporal gyrus were hypoactive in patients with depression. 19 Recently, Su and colleagues demonstrated that patients with depression consistently showed glucose metabolism changes in specific brain regions including the insular cortex, limbic system, basal ganglia, thalamus, and cerebellum, which were previously proposed in depression. 18 Our results corroborated some of the aforementioned results, since we observed glucose hypometabolism in both epileptic animal groups in some of the regions associated with depression. Furthermore, we observed that the depression associated with epilepsy decreases the glucose metabolism, starting at 23 days post-SE. In addition, we found glucose hypometabolism in the epileptic depressed group earlier and more pronounced than in the Pilo Nondepressed group. In the present study, animals were evaluated using micro-PET imaging during the interictal period. It is already known that in the ictal and postictal phase, the epileptic patients submitted to PET imaging present a cerebral glucose hypermetabolism, whereas in the interictal phase they show hypometabolism. 20 Studies in animal models have shown a higher pronounced hypometabolism during the SE and latent phase. 5, 8 Recently, Zhang and colleagues have shown that the hippocampal glucose hypometabolism during the latent phase was correlated with neuronal death and the partial recovery during the chronic period was due to elevated astrogliosis. 21 In contrast, during the chronic phase of epilepsy, the metabolism seems to undergo normalization, reestablishing the glucose uptake. 21, 22 However, studies are still controversial regarding cerebral glucose metabolism during the chronic phase of epilepsy. Jupp and coauthors observed a global decrease in cerebral glucose metabolism up to 6 weeks after SE induction, and it was not correlated with the SRS occurrence. 23 Akman and coauthors showed that glucose metabolism decreases in the epileptogenic temporal cortex with longer epilepsy duration. 24 Theodore and coauthors showed that longer epilepsy duration is associated with greater hypometabolism in patients, and they found no correlation between generalized tonic-clonic seizure history and cerebral glucose metabolism. 25 Conversely, our temporal analysis of brain glucose metabolism in both Pilo Depressed and Pilo Nondepressed In addition, we found no significant correlation between whole brain hypometabolism observed for the epileptic animals and SRS frequency during the chronic phase.
Furthermore, our results demonstrated a temporal change in glucose metabolism in control animals, which may be due to age and cerebral maturation. It was demonstrated that glucose uptake varies according to age and brain maturation, both in humans and rodents. 26, 27 F I G U R E 5 Depressive-like behavior in the sucrose preference test (SPT), forced swimming test (FST), and eating-related depression test (ERDT). A-C, The graphs show the consumption (mL) of sucrose solution and water for each experimental group. A, Graph shows that control animals consumed more sucrose solution than water (***P < .001). B, Graph shows that epileptic depressed animals consume similar amounts of water and sucrose solution. C, Graph shows that epileptic nondepressed animals consumed more sucrose solution than water (**P < .01). D, Graph shows a comparison between the groups in relation to the sucrose preference, which indicates that the Pilo Depressed group consumed a smaller amount of sucrose compared to the Control and Pilo Nondepressed groups (***P < .001; ##P < .01). E, Graph shows the duration of immobility during the first 5 minutes of testing, where animals in the Pilo Depressed group spent more time immobile than animals in the Control and Pilo Nondepressed groups (*P < .01; #P < .01). F, Graph shows the duration of immobility during the last 5 minutes of testing, where animals in the Pilo Depressed group spent more time immobile than animals in the Control and Pilo Nondepressed groups (*P < .05; #P < .05). G, Graph shows duration spent immobile during the total 10 minutes of the test, where animals in the Pilo Depressed group spent more time immobile than animals in the Control and Pilo Nondepressed groups (**P < .01; ##P < .01). H, Graph shows that the latency to the first bite of the food was significantly higher for animals in the Pilo Depressed group in comparison to animals in the Control and Pilo Nondepressed groups (**P < .01; ##P < .01). Data are expressed as mean AE SEM (Student's t-test for comparisons involved only 2 groups or 1-way ANOVA followed by post hoc Tukey for comparisons involved 3 groups). Control group, n = 13; Pilo Depressed group, n = 11; Pilo Nondepressed group, n = 9). SEM, standard error of mean Moreover, our results showed significant differences in glucose metabolism between the Pilo Depressed group and Pilo Nondepressed group in specific brain regions, such as left caudate putamen, left cerebellum, both superior colliculus, left auditory cortex, right parietal cortex, left retrosplenial cortex, left visual cortex, right hypothalamus, and bilateral thalamus. Most of these regions showed a greater hypometabolism in the Pilo Depressed group in relation to Pilo Nondepressed at 36 and 46 days post-SE. Particularly, the thalamus showed a persistent significant hypometabolism between the Pilo Depressed group and Pilo Nondepressed group over time. This region is described as involved in both epilepsy and depression. Holthoff and coauthors showed a decreased glucose metabolism in the thalamus from the acute to the remitted phase of depression in patients. 28 Of interest, Guo and colleagues, using the pilocarpine model of epilepsy, found a thalamic hypometabolism only in the animals that presented SRS during the chronic phase. 29 In the present study, the depression associated with epilepsy seems to contribute more to the decrease of cerebral glucose metabolism in this specific region. In the present study, through microPET we analyzed the cerebral metabolic network in rats with chronic epilepsy. The regions included in the metabolic network analysis were selected because they play an important role in the pathophysiology of epilepsy and/or depression such as the hippocampus, amygdala, cingulate cortex, entorhinal cortex, insular cortex, medial prefrontal cortex, orbitofrontal cortex, VTA, thalamus, and cerebellum.
Based on classic notions of neuroenergetics, it is a consensus that cerebral 18 F-FDG metabolism indicates brain energy consumption and, thus, brain activity. 27, 30 In this context, 18 F-FDG metabolism allows for the identification of interregional connections as an index of brain metabolic functional architecture. 15 With this in mind, we first used the previously delineated VOIs for establishing the control metabolic network by using an interregional cross-correlation analysis. We found a hypersynchronicity in the metabolic network in both the Pilo Depressed and Pilo Nondepressed group when compared to the Control group. Of interest, compared to the Pilo Nondepressed group, the Pilo Depressed group shows an increased number of significant connections. Abnormal brain connections in the epileptic brain have been reported involving different regions, mainly among the cortical and subcortical structures of the limbic system. 6 A review study showed that data on the epileptic network are still controversial, demonstrating that both decrease and increase in epileptic network synchronization are important characteristics of the disease. 31 A study using electroencephalography (EEG) demonstrated that the modulation of the network is related to high synchronization within each structure, mainly the entorhinal cortex and hippocampus. 32 However, another study demonstrated that decreased synchronization also plays a key role in seizure development. 33 Studies have
shown that the duration of epilepsy and frequency of seizures may influence the organization of the epileptic network. Morgan and colleagues showed that the initial interruption of interhippocampal connectivity evolves to an increase in connectivity after 10 years of TLE duration. 34 Choi and colleagues showed an abnormal metabolic network in epileptic animals, particularly involving lower connectivity between the left amygdala and the entorhinal cortex. 6 Furthermore, there are also controversial findings showing reduction and increase in the metabolic connectivity among different brain regions in depression. A study using a mouse model of depression showed more localized and decreased global connectivity by using EEG. 35 In the study by Fang and colleagues, they observed positive correlations in different regions, mainly implicating the insula, Table S9 and illustrated in Figure S3 hippocampus, amygdala, and temporal gyrus. 36 Another study using functional magnetic resonance imaging (fMRI) showed a higher functional connectivity between the cingulate cortex and thalamus in individuals with depression. 37 Our findings indicate that depression in chronic epilepsy is not associated with glucose hypometabolism restricted to these brain regions. However, depression seems to be the consequence of a more widespread disturbance of brain glucose metabolism determining a remodeling of the network into a hypersynchronous metabolic one. Our results provided additional evidence for the validation of depressive behavior as a comorbidity in the pilocarpine-induced epilepsy model using the SPT, FST, and ERDT. In the pilocarpine model, Mazarati and colleagues demonstrated a longer duration spent immobile during FST and lower sucrose intake in epileptic animals in SPT compared to control animals, 38 corroborating our results. In addition, they demonstrated that these behavioral depressive impairments were not related to nonspecific motor and sensory impairments induced by SE. 39, 40 Similarly, Bertoglio and colleagues demonstrated depression-like behavior in kainic acid epilepsy model using whisker nuisance task (WNT), SPT, and FST. 4 In addition, a correlation between 18 F -PBR111 PET imaging during epileptogenesis and comorbidities during chronic epilepsy has been demonstrated. 4 In the present study, we found a correlation between cerebral 18 F-FDG metabolism and depressive-like behavior in the whole brain and some specific regions related to epilepsy and depression in chronically epileptic rats. In addition, we showed changes in cerebral glucose metabolism and in the metabolic network synchronicity between epileptic depressed and nondepressed rats.
In conclusion, our results suggest an association between epilepsy and depression comorbidity based on changes in both cerebral glucose metabolism and functional metabolic network. More specifically, we have identified an association between decreased brain glucose hypometabolism and depressive-like behavior in animals presenting with chronic epilepsy. In addition, epileptic depressed animals presented a hypersynchronous network metabolic network, with aberrant connections identified in regions related to epilepsy and depression. Both epileptic groups presented hypometabolism in several brain regions; however, in epileptic depressed animals there is not only correlation with brain glucose hypometabolism, but also a widespread remodeling of the metabolic network architecture in brain regions associated with both epilepsy and depression. Thus, it seems that depression in epileptic animals is associated with a more diffuse brain glucose hypometabolism and a more compromised hypersynchronous network architecture.
Finally, our findings suggest that depressive behavior plays an important role in chronic epilepsy, which supports studies to better investigate the relationship between the 2 diseases and to further elucidate the mechanisms underlying depressive-like behavior in epilepsy.
